Moffitt Cancer Center and Florida Digestive Health Specialists, USA

Cancer champions – to the local community center… and beyond!
03 February 2022
Moffitt Cancer Center and Florida Digestive Health Specialists, USA
Shantou University Medical College, China
Specialisms: Cancer proteomics, Epigenetic toxicology, Epimodifications, Epithelial-mesenchymal plasticity
Inserm, University of Bordeaux, France
Specialisms: Tumor microenvironment, Glioblastoma, Metabolism, Autophagy
University of Central Florida, USA
Specialisms: Noncoding RNA, Regulation of gene expression, Cancer biology, Drug resistance
European Institute of Oncology, Italy
Twitter: @NicolaFuscoMD
Specialisms: Breast cancer, Pathology, Biomarkers, Translational medicine, Digital pathology, Predictive pathology, Molecular
National Cancer Institute, USA
Specialisms: Cancer biology, Multiple myeloma, Chemoresistance, Molecular imaging, Drug discovery and development
University of Pennsylvania, USA
Specialisms: Breast cancer therapeutics, Bone biology, Osteoclasts, Antibody engineering
Universidad Nacional Autónoma de México, Mexico
Specialisms: Voltage-Gated sodium channels, Beta subunits, Metastasis, Repurposing drugs
Sharda University School of Basic Sciences and Research, India
Specialisms: Extracellular vesicles (exosomes and microvesicles), Cancer, Kidney disease
University of Rhode Island, USA
Specialisms: Cancer immunotherapy, Immune checkpoints, Proteomics, Natural products
Washington University in Saint Louis, United States of America
Specialisms: Cancer Biology, Metabolism, Obesity, Radiation Oncology
University of Nebraska Medical Center, United States of America
Specialisms: Obesity, Diabetes, Insulin resistance, Cancer
The University of Queensland, Australia
Specialisms: Colon, Genetics, Endocrine
Stanford University, USA
Specialisms: Cancer treatment resistance, Tumor microenvironment, Ovarian cancer, Gastric cancer
H Lee Moffitt Cancer Center & Research Institute, USA
Specialisms: Tumor biology, Cancer stem cell, Epigenetics, Tumor microenvironment, Cell signalling, Drug resistance
Era University, India
Specialisms: Natural products, Anticancer and antiosteoporosis biological activities, In silico drug design and development
Morehouse School of Medicine, USA
Specialisms: Cancer, Drug delivery, Drug resistance, Targeted therapy, Combination therapy, Chemokines
Nagoya University Graduate School of Medicine, Japan
Specialisms: Lung cancer, Mesothelioma, Molecular biology, Cell culture
Shantou University Medical College, China
Specialisms: Cancer biology, Therapeutics, Natural compounds, Nutriepigenetics
H Lee Moffitt Cancer Center, United States of America
Specialisms: Hematology
The Johns Hopkins University School of Medicine, United States of America
Specialisms: Cancer Genetics, Next generation sequencing, Mutations, Solid tumors, Leukemia/lymphoma, Telomere
Sumit Agarwal, University of Alabama at Birmingham, USA
Raffaele Baffa, Shire, USA
Mariano Bizzarri, Sapienza University of Rome, Italy
Rocco Cappellesso, University of Padova, Italy
Kishore Challagundla, University of Nebraska Medical Center, USA
Gang Chen, Guangxi Medical University, China
Giuseppe Nicolò Fanelli, University of Padua, Italy
Matteo Fassan, University of Padua, Italy
Anjali Geethadevi, Medical College of Wisconsin, USA
Yuchao Jessica Gu, Stanford University, USA
Atif Hashmi, Liaquat National Hospital and Medical College, Pakistan
Giuseppe Ingravallo, University of Bari, Italy
Vivek Kashyap, University of Texas Rio Grande Valley, USA
Priyanka Khare, MD Anderson Cancer Center, USA
Yumin Li, Lanzhou University, China
Claudio Luchini, University of Verona, Italy
Chiara Mazzanti, Fondazione Pisana per la Scienz, Italy
Wenbo Meng, Lanzhou University, China
Subhadip Mukhopadhyay, New York University Langone Medical Center, USA
Antonio Giuseppe Naccarato, University of Pisa, Italy
Aejaz Nasir, Eli Lilly & Company, USA
Tamara Nikuševa-Martić, University of Zagreb, Croatia
Alessia Nottegar, San Bortolo Hospital of Vicenza, Italy
Nootan Pandey, University of Pennsylvania, USA
Jennifer Pasquier, Breast Cancer Institute - Nice Santa Maria, France
Sunila Pradeep, Medical College of Wisconsin, USA
Pradeep Chaluvally-Raghavan, Medical College of Wisconsin in Milwaukee, USA
Sahabjada, Era University, India
Marta Sbaraglia, Padua University Hospital, USA
Cristian Scatena, University of Pisa, Italy
Jumei Shi, Shanghai Tenth People’s Hospital, China
Shilpa Thakur, National Institutes of Health, USA
Zhenhua Zou, University of Michigan, USA
Elena Adinolfi, University of Ferrara, Italy
Faisal Aziz, University of Minnesota, USA
Michele Caraglia, Second University of Naples, Italy
Rosa A Cardone, University of Bari, Italy
Wenbin Chen, Zhejiang University School of Medicine, China
Zhijian Duan, University of California Davis, USA
Yi Hu, Shengjing Hospital of China Medical Univ., China and Univ. of California San Diego, USA
Tim Illidge, The University of Manchester, UK
Ruy Jaeger, University of Sao Paulo, Brazil
Xiaohua Jiang, The Chinese University of Hong Kong, Hong Kong
Manoj Kashyap, Amity University Haryana, India
Khandan Keyomarsi, MD Anderson Cancer Center, USA
Sajid Khan, University of Florida, USA
Vinod Kumar, University of Pittsburgh, USA
Mokenge Malafa, Moffitt Cancer Center, USA
Parvin Mehdipour, Tehran University of Medical Sciences, Iran
Javier A Menendez, Catalan Institute of Oncology (ICO) and Girona Biomedical Research Institute (IDIBGI), Spain
Sritama Nath, MedThink Communications, USA
Nives Pećina-Šlaus, University of Zagreb, Croatia
Geoffrey Pilkington, University of Portsmouth, UK
Tao Ren, Shanghai Jiao Tong University, China
Carlos Sonnenschein, Tufts University School of Medicine, USA
Christian Stock, Hannover Medical School, Germany
Carlos Telleria, McGill University, Canada
Koraljka Gall Trošelj, Ruđer Bošković Institute, Croatia
Sivakumar Vallabhapurapu, Indian Institute of Science Education and Research - Tirupati, India
Go J. Yoshida, Tokyo Medical and Dental University, Japan
Citation Impact
5.722 - 2-year Impact Factor
5.449 - 5-year Impact Factor
1.034 - Source Normalized Impact per Paper (SNIP)
1.322 - SCImago Journal Rank (SJR)
Speed
14 days to first decision for all manuscripts
67 days to first decision for reviewed manuscripts only
143 days from submission to acceptance
15 days from acceptance to publication
Usage
1,622,016 Downloads (2021)
393 Altmetric mentions
03 February 2022
16 April 2021
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).